Literature DB >> 15829255

Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.

Maria Lüttgen1, Elin Elvander, Nather Madjid, Sven Ove Ogren.   

Abstract

The role of the brain 5-HT1A receptor in cognition was examined in the water maze (WM) and passive avoidance (PA) tasks in the male rat. Pre-training administration of the 5-HT1A receptor agonist 8-OH-DPAT impaired WM performance and facilitated PA retention at low doses (0.01 and 0.03 mg/kg) and impaired PA retention at higher doses (0.1-1.0 mg/kg). The 5-HT1A receptor antagonist NAD-299 produced a dose-dependent facilitation of PA retention. In contrast, the 5-HT1A receptor antagonists NAD-299 and WAY-100635 failed to alter acquisition and retention in the WM. The impairments in WM and PA (but not facilitation in PA) induced by 8-OH-DPAT were blocked by NAD-299. Furthermore, NAD-299 prevented the PA impairments induced by the muscarinic antagonist scopolamine or the NMDA receptor antagonist MK-801. In contrast, NAD-299 and WAY-100635 failed to attenuate the WM impairment induced by scopolamine, probably due to the failure of 5-HT1A receptor blockade to attenuate the sensorimotor disturbances induced by scopolamine. These results indicate that 5-HT1A receptor stimulation and blockade result in opposite effects in two types of cognitive tasks in the rat, and that 5-HT1A receptor blockade can facilitate some aspects of cognitive function, probably via modulation of cholinergic and glutamatergic transmissions. This suggests that 5-HT1A receptor antagonists may have a potential role in the treatment of human degenerative disorders associated with cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829255     DOI: 10.1016/j.neuropharm.2005.01.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  20 in total

1.  Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

Authors:  Adam S Olsen; Christopher N Sozda; Jeffrey P Cheng; Ann N Hoffman; Anthony E Kline
Journal:  J Neurotrauma       Date:  2012-04-23       Impact factor: 5.269

Review 2.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

Review 3.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

4.  The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.

Authors:  Simin Afshar; Siamak Shahidi; Ali Haeri Rohani; Alireza Komaki; Sara Soleimani Asl
Journal:  Psychopharmacology (Berl)       Date:  2018-07-19       Impact factor: 4.530

5.  GABA concentration and GABAergic neuron populations in limbic areas are differentially altered by brain serotonin deficiency in Tph2 knockout mice.

Authors:  Jonas Waider; Florian Proft; Georg Langlhofer; Esther Asan; Klaus-Peter Lesch; Lise Gutknecht
Journal:  Histochem Cell Biol       Date:  2012-10-11       Impact factor: 4.304

6.  Activation of postsynaptic 5-HT1A receptors improve stress adaptation.

Authors:  Jiansong Zhou; Xia Cao; Adam C Mar; Yu-Qiang Ding; Xiaoping Wang; Qi Li; Lingjiang Li
Journal:  Psychopharmacology (Berl)       Date:  2013-11-21       Impact factor: 4.530

7.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

8.  Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.

Authors:  Xue Sun; Hong-yan Gou; Fei Li; Guan-yi Lu; Rui Song; Ri-fang Yang; Ning Wu; Rui-bin Su; Bin Cong; Jin Li
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

9.  Knockdown and overexpression of NR1 modulates NMDA receptor function.

Authors:  Maggie L Kalev-Zylinska; Wymond Symes; Deborah Young; Matthew J During
Journal:  Mol Cell Neurosci       Date:  2009-04-24       Impact factor: 4.314

10.  Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions--a strategy in translational psychopharmacology.

Authors:  Jacqueline Borg; Bengt Andrée; Johan Lundberg; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.